Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 406 | 495 | 467 | 753 | 301 |
| Cost of Goods | 1,231 | 2,038 | 9,082 | 260 | 213 |
| Gross Profit | -825 | -1,543 | -8,615 | 493 | 88 |
| Operating Expenses | 26,402 | 27,430 | 22,303 | 25,143 | 30,028 |
| Operating Income | -26,996 | -28,935 | -30,836 | -24,390 | -29,727 |
| Interest Expense | 2,321 | 2,271 | 3,093 | 2,612 | 2,545 |
| Other Income | -7,485 | 13,587 | 9,125 | 9,492 | -5,386 |
| Pre-tax Income | -36,802 | -17,619 | -24,804 | -17,510 | -37,658 |
| Net Income Continuous | -36,802 | -17,619 | -24,804 | -17,510 | -37,658 |
| Net Income | $-36,802 | $-17,619 | $-24,804 | $-17,510 | $-37,658 |
| EPS Basic Total Ops | -0.16 | -0.09 | -0.19 | -0.11 | -0.24 |
| EPS Basic Continuous Ops | -0.16 | -0.09 | -0.20 | -0.11 | -0.24 |
| EPS Diluted Total Ops | -0.16 | -0.09 | -0.19 | -0.11 | -0.24 |
| EPS Diluted Continuous Ops | -0.16 | -0.09 | -0.20 | -0.11 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -0.09 | -0.13 | -0.14 | -0.24 |
| EBITDA(a) | $-24,912 | $-26,863 | $-29,048 | $-22,525 | $-27,867 |